Anaesthesia for Carotid Endarterectomy

Quick Answer

Carotid endarterectomy (CEA) removes atherosclerotic plaque to prevent stroke. Indications: Symptomatic carotid stenosis >50-70% (recent TIA/stroke), asymptomatic >80% (selective). Monitoring: Arterial line, cerebral monitoring (awake patient neurological assessment, stump pressure <40-50 mmHg, EEG changes, TCD MCA velocity decrease >50%), cardiac monitoring (high cardiac risk). Anaesthesia: GA (most common) or local/regional (allows direct neurological monitoring). Hemodynamic goals: Maintain normotension (avoid hypotension which causes cerebral ischemia, avoid hypertension which causes cerebral hyperperfusion syndrome or neck hematoma). Shunting: If cerebral ischemia detected (carotid shunt placed to bypass cross-clamp). Postoperative: Blood pressure control crucial, watch for neck hematoma (airway obstruction), neurological assessment, myocardial ischemia monitoring. [1-10]

Pathophysiology

Carotid Artery Disease

Anatomy:

• Common carotid: Bifurcates into external (ECA) and internal (ICA)
• Internal carotid: Supplies ipsilateral cerebral hemisphere (anterior circulation)
• Circle of Willis: Anastomotic connection between carotid and vertebral systems
• Collateral flow: Critical during ICA cross-clamp

Atherosclerosis:

• Location: Carotid bifurcation (external carotid origin, bulb)
• Pathology: Plaque formation, stenosis, ulceration, embolization
• Mechanism of stroke:
  1. Embolic: Plaque embolization to cerebral circulation
  2. Hemodynamic: Severe stenosis → hypoperfusion
  3. Thrombotic: Acute occlusion

Indications for Surgery:

• Symptomatic (recent TIA, stroke, amaurosis fugax):

  • 50% stenosis (NASCET criteria)

  • Benefit greater with >70% stenosis
  • Surgery within 2 weeks of event (optimal)
• Asymptomatic:

  • 60-80% stenosis (controversial, ACST trial showed benefit)

  • Selective (life expectancy >5 years, low surgical risk)

Cerebral Perfusion During Cross-Clamp

Cross-Clamp Physiology:

• Mechanism: Carotid clamped above and below plaque → no flow to ipsilateral hemisphere
• Duration: Variable (10-60 minutes typical)
• Consequences:
  • Cerebral ischemia if inadequate collateral flow
  • Risk highest in first 2-3 minutes
  • Tolerance depends on:
    • Circle of Willis completeness
    • Contralateral carotid patency
    • Baseline blood pressure
    • Cerebrovascular reserve

Collateral Circulation:

• Circle of Willis: Communicating arteries between carotid and vertebral systems
• Incomplete in: 20-40% of population (hypoplastic or absent posterior communicating arteries)
• Assessment: Preoperative imaging (CTA, MRA, angiography)
• Testing: Preoperative balloon occlusion test (optional)

Cerebral Monitoring:

1. Awake Patient (Local/Regional):

• Gold standard: Direct neurological assessment
• Patient awake: Speaks, moves contralateral hand/foot
• Monitoring: Continuous conversation, motor tasks
• Advantage: Most sensitive for ischemia
• Disadvantage: Patient discomfort, anxiety, movement risk

2. Stump Pressure:

• Measurement: Pressure in ICA distal to cross-clamp (back pressure from collaterals)
• Threshold: <40-50 mmHg indicates inadequate collateral flow
• Interpretation:

  • 50 mmHg: Usually safe (90% no ischemia)

  • <40 mmHg: High risk (shunt indicated)
• Limitations: Poor correlation with neurological outcome in some studies

3. Electroencephalography (EEG):

• Changes with ischemia:
  • Slowing (theta, delta waves)
  • Loss of fast activity (alpha, beta)
  • Asymmetry (>50% amplitude reduction ipsilateral)
• Threshold: >50% amplitude reduction or slowing indicates ischemia
• Sensitivity: 80-90%
• Specificity: 70-80%
• Bilateral monitoring: For comparison

4. Transcranial Doppler (TCD):

• Measurement: MCA (middle cerebral artery) velocity via temporal window
• Change: >50% decrease in velocity indicates inadequate flow
• Emboli detection: Microembolic signals (MES) during dissection/shunting
• Limitations: 10-15% inadequate temporal window (obesity, age)

5. Cerebral Oximetry (Near-Infrared Spectroscopy - NIRS):

• Measurement: Regional cerebral oxygen saturation (rSO₂)
• Change: >20% decrease from baseline indicates ischemia
• Advantage: Non-invasive, continuous
• Limitation: Not specific to clamped side (measures both hemispheres)
• Trend: Useful as adjunct

6. Somatosensory Evoked Potentials (SSEPs):

• Median nerve stimulation: cortical response
• Change: >50% amplitude reduction or >10% latency increase
• Sensitivity: Similar to EEG
• Used in: GA cases

Shunt Indications:

• Awake patient: Neurological changes (speech, motor deficit)
• GA with monitoring: EEG slowing >50%, stump pressure <40-50 mmHg, TCD MCA velocity ↓>50%, SSEP changes
• Prophylactic: Some surgeons shunt all patients, some selective based on monitoring

Hyperperfusion Syndrome

Mechanism:

• Postoperative: Loss of autoregulation in chronically hypoperfused territory
• Cerebral blood flow: Increases dramatically (autoregulation impaired)
• Risk factors: High-grade stenosis, contralateral occlusion, hypertension
• Timing: Usually 3-7 days postoperatively (can be immediate)

Clinical Features:

• Headache: Ipsilateral, severe, throbbing
• Seizures: Focal or generalized
• Focal deficits: Mimics stroke (Todd's paralysis)
• Intracerebral hemorrhage: Catastrophic complication
• Edema: Cerebral edema on imaging

Prevention:

• Blood pressure control: Strict normotension postoperatively
• Avoid hypertension: Reduces risk

Clinical Presentation

Preoperative Assessment

History:

• Symptoms: TIA, stroke, amaurosis fugax (transient monocular blindness), vertebrobasilar symptoms
• Timing: Days to weeks since event
• Cardiac history: CAD common (co-existing atherosclerosis)
• Risk factors: Hypertension, smoking, diabetes, hyperlipidemia
• Medications: Antiplatelets (aspirin, clopidogrel), statins, antihypertensives

Physical Examination:

• Neurological: Baseline deficits (document for comparison)
• Cardiovascular: Murmurs, peripheral pulses, signs of heart failure
• Airway: Assessment (cervical spine mobility if awake technique)

Investigations:

• Carotid imaging:
  • Duplex ultrasound (first-line)
  • CTA or MRA (anatomy, intracranial vessels)
  • Digital subtraction angiography (gold standard, rarely needed)
• Cardiac:
  • ECG (ischemia, arrhythmia)
  • Echocardiography (LV function, wall motion, valve disease)
  • Stress test if indicated (high-risk patients)
• Cerebral:
  • CT/MRI brain (prior infarcts, baseline)
  • CTA head/neck (circle of Willis)
• Laboratory: FBC, coagulation, creatinine, electrolytes
• Pulmonary: CXR if indicated

Risk Stratification:

• Cardiac risk: Major determinant of perioperative morbidity/mortality
• Neurological risk: Stroke risk 2-5% (symptomatic higher)
• Comorbidities: Age, diabetes, renal disease, COPD

Choice of Anaesthesia

Controversy:

• GA vs Local/Regional: Debated for decades
• GALA Trial: Large RCT showed no difference in stroke/death between GA and local
• Current practice: Surgeon and anaesthetist preference, patient factors

General Anaesthesia:

• Advantages:
  • Patient comfort, stillness
  • Control of ventilation (PaCO₂, PaO₂)
  • Airway protection (if neurological event occurs)
  • TCD monitoring easier (no movement)
• Disadvantages:
  • Cannot do direct neurological exam
  • Requires cerebral monitoring (EEG, TCD, SSEP)
  • Hemodynamic lability

Local/Regional (Cervical Plexus Block):

• Technique: Superficial + deep cervical plexus block (C2-C4)
• Advantages:
  • Direct neurological monitoring (awake patient)
  • Hemodynamic stability
  • Reduced shunt use (direct ischemia detection)
  • Shorter hospital stay (some studies)
• Disadvantages:
  • Patient discomfort, anxiety
  • Risk of movement (seizure if ischemia)
  • Airway compromise (phrenic nerve block, hematoma)
  • Cannot control ventilation
  • Local anaesthetic toxicity risk
  • Time to perform block

Decision Factors:

• Patient: Anxiety, claustrophobia, understanding, cervical spine disease
• Surgical: Duration, complexity (shunt likely?), surgeon comfort
• Anaesthetic: Experience with awake techniques, monitoring available
• Institutional: Practice patterns, resources

Management

General Anaesthesia Technique

Monitoring:

• Standard: ECG, SpO₂, NIBP, EtCO₂
• Arterial line: Essential (beat-to-beat BP, frequent gases)
• Cerebral monitoring (choose 1-2):
  • EEG (bilateral, processed or raw)
  • TCD (MCA velocity)
  • SSEPs
  • NIRS (regional oximetry)
• Urinary catheter: Optional for short cases

Induction:

• Goals: Hemodynamic stability (avoid hypotension)
• Technique:
  • Etomidate 0.2-0.3 mg/kg (hemodynamically stable) OR
  • Propofol reduced dose (cautiously) OR
  • Ketamine (sympathomimetic, maintains BP)
• Muscle relaxation: Rocuronium or atracurium (for TCD monitoring, avoid movement)
• Airway: ETT (secure, controlled ventilation)

Maintenance:

• TIVA or balanced: Either acceptable
• Avoid: Deep anaesthesia (impairs cerebral monitoring), hypotension
• Ventilation:
  • Normocapnia (PaCO₂ 35-40 mmHg)
  • Avoid hypocapnia (cerebral vasoconstriction, ischemia)
  • Avoid hypercapnia (cerebral vasodilation, steal phenomenon)
  • High normal PaO₂ (>100 mmHg)

Hemodynamic Management:

• Pre-cross-clamp: Normotension or slight hypertension (MAP 80-100 mmHg)
• During cross-clamp:
  • Maintain MAP at or above baseline (promotes collateral flow)
  • Phenylephrine or noradrenaline if needed
  • Avoid hypotension (cerebral ischemia)
• Post-clamp release:
  • Gradual reduction to baseline
  • Avoid severe hypertension (hyperperfusion risk, hematoma)
  • Target MAP 70-90 mmHg

Shunt Management:

• Insertion: If cerebral ischemia detected
• Anaesthetic implications:
  • Brief period to insert (ischemia continues briefly)
  • Heparinization (3000-5000 units) before shunt (prevent thrombosis)
  • Reverse heparin if needed (protamine)
• Removal: Before closure, check for back-bleeding

Emergence:

• Goal: Rapid, smooth (neurological assessment)
• Reversal: Sugammadex (faster) or neostigmine
• Blood pressure: Well-controlled before emergence (avoid coughing/straining)
• Extubation: Awake, following commands

Local/Regional Technique

Cervical Plexus Block:

Anatomy:

• Cervical plexus: C1-C4 ventral rami
• Superficial: Supplies skin over anterior/lateral neck
• Deep: Supplies deeper structures (carotid sheath, sternocleidomastoid)

Technique:

• Superficial cervical plexus:
  • Landmark: Posterior border sternocleidomastoid at midpoint
  • LA: 10-15 mL 0.5-1% ropivacaine or 0.25-0.5% bupivacaine
  • Subcutaneous/intramuscular infiltration along posterior border
• Deep cervical plexus (optional, adds risk):
  • Landmark: C4 transverse process (Chassaignac's tubercle)
  • LA: 5-8 mL per level (C2, C3, C4)
  • Risk: Phrenic nerve block, intravascular, spinal/epidural

Monitoring:

• Patient: Conscious, responsive
• Tasks: Count backwards, squeeze hand, lift leg
• Speech: Continuous conversation
• Anaesthetist: At head, talks to patient continuously
• Safety: Immediate access to induce GA if needed

Supplementation:

• Local infiltration: By surgeon (carotid sheath, deep tissues)
• Sedation: Minimal (dexmedetomidine 0.2-0.4 μg/kg/hour - arousable, no respiratory depression)
  • Avoid: Propofol (may impair neurological exam), benzodiazepines (amnesia, respiratory depression)
• Analgesia: Short-acting opioids (remifentanil, alfentanil) if needed

Complications of Block:

• Phrenic nerve block: C3-C5 (hemidiaphragm paralysis - usually well-tolerated)
• Recurrent laryngeal nerve: Hoarseness (usually transient)
• Stellate ganglion: Horner's syndrome (ptosis, miosis, anhidrosis)
• Vagus nerve: Voice changes
• Spinal/epidural: Total spinal (rare, devastating - resuscitation ready)
• Local anaesthetic toxicity: Seizures, cardiovascular collapse
• Pneumothorax: Apex of lung (rare)

Converting to GA:

• Indications: Seizure, severe ischemia, stroke, airway compromise, patient intolerance
• Technique: Rapid sequence (full stomach)
• Monitoring: Continue cerebral monitoring if possible

Perioperative Management

Blood Pressure Control:

• Critical for outcomes
• Preoperative: Continue antihypertensives (morning of surgery)
• Intraoperative:
  • Avoid hypotension (cerebral ischemia)
  • Maintain MAP 80-100 mmHg (during clamp)
  • Phenylephrine, noradrenaline as needed
• Postoperative:
  • Strict normotension (avoid hyperperfusion)
  • Target SBP 100-140 mmHg
  • Hydralazine, labetalol, GTN if hypertensive
  • Phenylephrine if hypotensive

Antiplatelet Therapy:

• Continue aspirin: Through surgery (reduces stroke/MI)
• Clopidogrel: Usually stopped 5-7 days preop if elective (bleeding risk)
  • Continue if recent stent or high stroke risk
  • Accept increased bleeding risk

Heparin:

• Before cross-clamp: 3000-5000 units IV (surgeon preference)
• Shunt insertion: Higher dose (5000-7000 units)
• Reversal: Rarely needed (unless excessive bleeding), protamine 30-50 mg

Statin Therapy:

• Continue: Statin therapy (perioperative cardiovascular protection)
• Intensive: High-dose statin (atorvastatin 80 mg) started preoperatively

Postoperative Care

Immediate (PACU):

• Neurological assessment: Serial exams (q15min initially)
  • New deficit: Urgent CT scan (stroke vs hemorrhage)
• Blood pressure: Strict control (100-140 mmHg systolic)
• Cardiac monitoring: High risk MI (first 48 hours)
• Airway: Watch for neck hematoma
  • Hoarseness, dysphagia, respiratory distress
  • Rapid intubation kit at bedside
  • Evacuation if expanding hematoma

Complications to Monitor:

1. Stroke: 2-5% incidence
   • Ipsilateral (clamp-related, embolic)
   • Contralateral (embolic)
   • Hyperperfusion hemorrhage (delayed)
2. Myocardial infarction: 2-5% incidence
3. Neck hematoma: 2-5%, can cause airway obstruction
   • Evacuation if expanding, respiratory compromise
4. Cranial nerve injury:
   • Hypoglossal (XII) - tongue deviation
   • Recurrent laryngeal - hoarseness
   • Marginal mandibular - facial asymmetry
   • Glossopharyngeal - dysphagia
5. Hyperperfusion syndrome: 1-2%
   • Severe headache, seizures, hemorrhage
6. Death: 1-2% (cardiac causes most common)

Discharge:

• Usually: Day 1-2 postoperative
• Follow-up: Carotid duplex at 1 month, then annually
• Medical therapy: Continue aspirin, statin, BP control

Indigenous Health Considerations

Aboriginal and Torres Strait Islander Patients

Higher Cardiovascular Risk:

• Higher rates: Stroke, IHD, peripheral vascular disease
• Risk factors: Hypertension, smoking, diabetes, renal disease
• Earlier onset: Vascular disease 10-20 years younger

Access Issues:

• Geographic: Remote communities far from vascular surgical centers
• Delayed presentation: May present with established stroke (too late for CEA)
• Secondary prevention: Challenges with medication adherence
• Follow-up: Remote monitoring difficult

Cultural Considerations:

• Communication: Clear explanations of stroke prevention
• Family involvement: Extended family in decision-making
• Fear of surgery: Address concerns, provide support
• Lifestyle modification: Smoking cessation, diet, exercise programs

Māori Health Considerations

Cardiovascular Disease:

• Higher rates of stroke and vascular disease
• Cardiovascular mortality disparities

Cultural Safety:

• Whānau involvement: Family support for vascular surgery
• Communication: Risk/benefit discussion in culturally appropriate manner
• Discharge planning: Ensure follow-up access
• Secondary prevention: Support for lifestyle modification

ANZCA Final Exam Focus

SAQ Patterns

Common Questions:

• "Describe the anaesthetic management for carotid endarterectomy under general anaesthesia."
• "What cerebral monitoring techniques are used during carotid surgery?"
• "Compare general anaesthesia vs local anaesthesia for CEA."
• "How would you manage a patient who develops neurological deficit during carotid cross-clamp?"

Marking Scheme Priorities:

• Cerebral monitoring options (stump pressure, EEG, TCD, awake assessment)
• Hemodynamic goals (avoid hypotension during clamp)
• BP management pre/during/post-surgery
• Shunt indications
• Postoperative complications (stroke, MI, hematoma, hyperperfusion)

Viva Scenarios

Scenario 1: Cross-Clamp Neurological Changes

• GA case, EEG slowing >50%
• Increase BP (phenylephrine)
• Consider shunt if not improving

Scenario 2: Postoperative Hypertension

• SBP 180 mmHg in PACU
• Risk: Hyperperfusion, hematoma
• Treat: Labetalol, hydralazine, GTN
• Strict control 100-140 mmHg

Scenario 3: Neck Hematoma

• Expanding neck swelling, airway compromise
• Rapid sequence intubation (difficult airway cart ready)
• Evacuation in OR
• Watch for stroke (compression of ICA)

Key Points for Examination Success

1. Monitoring: Arterial line essential, cerebral monitoring (EEG, TCD, stump pressure, or awake patient)
2. Hemodynamics: Avoid hypotension (ischemia), maintain MAP 80-100 mmHg during clamp
3. Shunt indications: Awake deficit, EEG slowing >50%, stump pressure <40-50 mmHg, TCD ↓>50%
4. Postoperative BP: Strict control 100-140 mmHg (prevent hyperperfusion and hematoma)
5. GA vs Local: GALA trial showed no difference in outcomes, choice based on preferences/resources
6. Complications: Stroke 2-5%, MI 2-5%, hematoma 2-5% (airway risk), hyperperfusion 1-2%
7. Antiplatelets: Continue aspirin (reduces stroke/MI)
8. Conversion: Awake to GA if seizure, severe ischemia, stroke, airway compromise

References

1. ANZCA. PS48. Statement on Anaesthesia Care of Patients with Cerebrovascular Disease. 2019.
2. GALA Trial Collaborative Group. General anaesthesia versus local anaesthesia. Lancet. 2008;372(9656):2132-2142.
3. NASCET Collaborators. Beneficial effect of carotid endarterectomy. N Engl J Med. 1991;325(7):445-453.
4. ACST Collaborators. Prevention of disabling and fatal strokes. Lancet. 2004;363(9420):1491-1502.
5. McCleary AJ et al. Anaesthesia for carotid surgery. In: Cottrell JE (ed). Cottrell and Patel's Neuroanesthesia. 6th ed. Elsevier; 2017:313-328.
6. Stoneham MD et al. Anaesthesia for carotid endarterectomy. BJA CEPD Reviews. 2003;3(6):170-174.
7. Chauhan A et al. Cerebral monitoring during carotid endarterectomy. Curr Opin Anaesthesiol. 2021;34(5):532-538.
8. ATSI Health. Stroke and cerebrovascular disease in Aboriginal and Torres Strait Islander peoples. Australian Institute of Health and Welfare; 2020.